Table 1.
Values are presented as n or median (interquartile range)
| Characteristics | n = 303 |
|---|---|
|
Age (yrs) |
63 (55–70) |
|
Sex |
|
| Male |
202 |
| Female |
101 |
|
Body mass index (kg/m2) |
26.2 (24.1-29.0) |
|
Hypertension* |
|
| Yes |
147 |
| No |
126 |
|
Diabetes mellitus* |
|
| Yes |
20 |
| No |
253 |
|
Smoker† |
|
| Yes |
42 |
| No |
230 |
|
Family history of CAD† |
|
| Yes |
77 |
| No |
195 |
|
Laboratory profile |
|
| LDL-cholesterol (mg/dl) |
122 (95–149) |
| HDL-cholesterol (mg/dl) |
52 (44–59) |
| Triglycerides (mg/dl) |
143 (106–207) |
| High-sensitivity CRP (mg/dl) |
0.23 (0.05-0.54) |
| TNFa (pg/ml) |
6,3 (4.5-7.9) |
| eGFR (ml/min) |
71 (63–80) |
| IL6 (pg/ml) |
0 (0–3.2) |
| GLP-1 (pM) |
2.9 (1.5-4.9) |
|
Medical treatment‡ |
|
| Statin |
120 |
| Aspirin, Plavix or Marcumar |
170 |
| Betablocker |
173 |
| ACE-I or ARB |
138 |
| Diuretics |
87 |
| Insulin or OAD |
16 |
|
CT data |
|
|
Pericardial adipose tissue volume (ml)§ |
190 (132–259) |
|
Number of coronary artery plaques (total)|| |
3 (1–6) (range 0–26) |
| Number of calcified plaques |
1 (0–3) (range 0–22) |
| Number of mixed plaques | 0 (0–1) (range 0–10) |
*History of diabetes and hypertension is known in 273 patients.
†History of smoking and family history of CAD is known in 272 patients.
‡Medication is known in 258 patients.
§Adequate image quality for evaluation of PAT volume was obtained in 287 patients.
||Adequate image quality for evaluation of coronary plaques was obtained in 281 patients.